laboratori
investig
uscap
inc
right
reserv
nontraumat
osteonecrosi
femor
head
onfh
often
occur
corticosteroid
therapi
patient
inflammatori
diseas
recent
studi
suggest
tolllik
receptor
tlr
signal
may
contribut
pathogenesi
inflammatori
diseas
reason
corticosteroid
therapi
inflammatori
diseas
relat
antiinflammatori
activ
corticosteroid
reduct
nfkb
hypothes
administr
tlr
ligand
combin
corticosteroid
caus
onfh
transcript
factor
may
contribut
pathogenesi
onfh
aim
studi
evalu
incid
onfh
rat
administr
ligand
togeth
methylprednisolon
mpsl
whether
transcript
factor
contribut
develop
onfh
male
wistar
rat
n
divid
five
group
follow
group
salin
mpsl
group
imiquimod
salin
group
imiquimod
mpsl
group
cpgc
mpsl
group
imiquimod
mpsl
result
onfh
observ
rat
group
group
group
group
group
mpsl
treatment
significantli
affect
activ
wherea
nfkb
activ
significantli
repress
group
group
furthermor
repress
interferon
regulatori
factor
activ
interf
develop
onfh
simultan
mpsl
treatmentinduc
repress
nfkb
activ
conclus
present
studi
corticosteroid
treatment
administr
ligand
caus
onfh
repress
nfkb
activ
corticosteroid
treatment
boost
develop
onfh
highdos
corticosteroid
therapi
inflammatori
diseas
autoimmun
diseas
report
risk
factor
nontraumat
osteonecrosi
femor
head
onfh
hand
report
megados
corticosteroid
therapi
traumat
spinal
cord
injuri
induc
nontraumat
onfh
thu
role
corticosteroid
pathogenesi
nontraumat
onfh
poorli
understood
previous
report
tolllik
receptor
tlr
signal
pathway
induc
inflammatori
statu
contribut
pathogenesi
nontraumat
onfh
rat
tlr
identifi
receptor
relat
innat
immun
system
recent
tlr
report
play
crucial
role
autoimmun
particular
tlr
contribut
pathogenesi
underli
diseas
system
lupu
erythematod
sle
nephrot
syndrom
polymyositisdermatmyos
bronchial
asthma
thrombocytopen
purpura
patient
corticosteroidinduc
onfh
signal
pathway
via
type
interferon
may
particular
contribut
pathogenesi
system
autoimmun
diseas
sle
inhibitor
biolog
develop
downregul
signal
pathway
treatment
inflammatori
diseas
reason
use
corticosteroid
therapi
inflammatori
diseas
relat
antiinflammatori
immunosuppress
activ
corticosteroid
report
reduct
nuclear
factor
kappa
b
nfkb
activ
via
glucocorticoid
receptor
central
role
activ
nfkb
interferon
regulatori
factor
signal
transcript
factor
relat
proinflammatori
respons
via
pathway
thu
hypothes
administr
ligand
subsequ
treatment
methylprednisolon
mpsl
lead
onfh
rat
transcript
factor
may
contribut
pathogenesi
onfh
via
tlr
present
studi
verifi
hypothesi
investig
incid
onfh
rat
administr
ligand
combin
mpsl
whether
nfkb
contribut
pathogenesi
onfh
mpsl
treatment
experi
conduct
accord
guidelin
ministri
sport
cultur
scienc
technolog
japan
follow
protocol
approv
anim
ethic
committe
sapporo
medic
univers
male
wistar
rat
g
obtain
sankyo
labo
servic
sapporo
japan
anim
hous
temperatureand
humiditycontrol
room
unlimit
food
water
lightdark
cycl
anim
n
divid
five
group
treat
follow
tabl
salin
mpsl
rat
n
given
salin
mlkg
subcutan
day
mgkg
mpsl
sigma
st
loui
mo
usa
intramuscularli
day
imiquimod
salin
rat
n
given
mgkg
imiquimod
tokyo
chemic
industri
tokyo
japan
ligand
subcutan
day
salin
mlkg
intramuscularli
day
imiquimod
mpsl
rat
n
given
mgkg
imiquimod
subcutan
day
mgkg
mpsl
intramuscularli
day
cpgc
mpsl
rat
n
given
mgkg
cpgc
ligand
subcutan
day
mgkg
mpsl
intramuscularli
day
imiquimod
mpsl
rat
n
given
mgkg
imiquimod
subcutan
day
mgkg
sigma
inhibitor
kappab
kinas
ikk
b
potenti
inhibit
nfkb
activ
intraperitoneali
mgkg
mpsl
intramuscularli
day
inject
perform
pm
anim
kill
day
last
inject
femur
liver
harvest
fix
phosphat
buffer
ph
bone
sampl
decalcifi
kalkitox
wako
pure
chemic
industri
osaka
japan
neutral
sodium
sulfat
buffer
tissu
process
routin
hematoxylin
eosin
stain
assess
gener
architectur
onfh
osteonecrosi
defin
present
studi
diffus
presenc
empti
lacuna
pyknot
nuclei
osteocyt
within
bone
trabecula
accompani
surround
bone
marrow
cell
necrosi
electrophoret
mobil
shift
assay
nfkb
activ
assess
electrophoret
mobil
shift
assay
describ
previous
brief
equal
amount
liver
nuclear
extract
mg
protein
incub
h
room
temperatur
plabel
nfkb
consensu
oligonucleotid
probe
agttga
actgatcggaaccga
respect
bind
buffer
mm
hepe
ph
mm
kcl
mm
ethylenediaminetetraacet
acid
mm
dithiothreitol
glycerol
dna
protein
complex
separ
nondenatur
polyacrylamid
gel
constant
voltag
v
room
temperatur
gel
expos
imag
plate
fuji
film
tokyo
japan
room
temperatur
radioact
dnabind
complex
gel
analyz
use
imag
analyz
fuji
film
imagequ
softwar
molecular
dynam
sunnyval
ca
usa
data
repres
mean
sem
comparison
two
group
perform
use
fisher
exact
test
unpair
ttest
welch
correct
pvalu
consid
signific
statist
analysi
perform
use
graphpad
prism
softwar
mac
os
x
graphpad
softwar
la
jolla
ca
usa
evalu
incid
onfh
rat
salin
mpsl
n
use
control
imiquimod
mpsl
n
cpgc
mpsl
n
group
kill
day
mpsl
inject
onfh
observ
rat
imiquimod
mpsl
group
rat
cpgc
mpsl
group
contrast
onfh
observ
salin
mpsl
group
tabl
incid
onfh
imiquimod
mpsl
group
significantli
higher
salin
mpsl
group
fisher
exact
test
figur
show
tlr
stimul
induc
osteonecrosi
okazaki
et
al
histopatholog
appear
femor
head
hematoxylin
eosin
stain
salin
mpsl
imiquimod
mpsl
b
cpgc
mpsl
c
rat
normal
trabecula
well
hematopoiet
fat
cell
observ
salin
mpsl
rat
figur
imiquimod
mpsl
cpgc
mpsl
group
empti
lacuna
pyknot
nuclei
observ
within
necrot
bone
trabecula
bone
marrow
cell
necrosi
observ
medullari
space
across
area
femor
head
figur
c
elucid
precis
time
onset
onfh
rat
evalu
effect
mpsl
onfh
develop
imiquimod
salin
n
n
use
control
group
imiquimod
mpsl
n
group
group
significantli
develop
onfh
compar
salin
mpsl
group
divid
four
equal
subgroup
one
subgroup
treatment
group
killd
day
respect
last
treatment
detect
chang
led
develop
onfh
tabl
show
incid
onfh
group
onfh
observ
imiquimod
salin
imiquimod
mpsl
rat
kill
day
figur
show
histopatholog
appear
femor
head
hematoxylin
eosin
stain
imiquimod
salin
rat
onfh
without
onfh
b
day
empti
lacuna
observ
within
necrot
bone
trabecula
bone
marrow
cell
show
fat
cell
necrosi
observ
medullari
space
across
area
femor
head
observ
imiquimod
mpsl
cpgc
mpsl
rat
figur
normal
trabecula
well
hematopoiet
fat
cell
observ
femor
head
observ
salin
mpsl
rat
figur
present
studi
found
onfh
occur
within
day
mpsl
treatment
rat
figur
show
activ
transcript
factor
nfkb
liver
activ
nfkb
repress
significantli
rat
treat
mpsl
day
administr
tlr
ligand
figur
imiquimod
salin
vs
imiquimod
mpsl
vs
howev
mpsl
treatment
alter
activ
phase
either
group
figur
inhibit
interfer
develop
onfh
describ
observ
chang
transcript
factor
activ
liver
h
mpsl
treatment
hypothes
chang
might
trigger
onset
primari
corticosteroidinduc
onfh
repress
activ
use
inhibitor
could
interfer
develop
onfh
spite
simultan
repress
nfkb
activ
result
mpsl
treatment
clarifi
hypothesi
imiquimod
mpsl
n
n
receiv
mgkg
respect
group
kill
day
mpsl
treatment
tabl
show
incid
onfh
group
coadministr
mpsl
found
interfer
develop
onfh
figur
histolog
appear
femor
head
affect
osteonecrosi
panel
show
hematoxylin
eosinstain
femur
typic
imag
imiquimod
salin
group
onfh
without
onfh
b
shown
diffus
presenc
empti
lacuna
pyknot
osteocyt
nuclei
bone
trabecula
accompani
bone
marrow
cell
necrosi
also
observ
femor
head
rat
onfh
scale
bar
mm
dosedepend
manner
group
coadminist
mgkg
onfh
observ
mpsl
treatment
incid
onfh
group
coadminist
mgkg
significantli
less
imiquimod
mpsl
group
p
fisher
exact
test
howev
rat
die
within
day
administr
mgkg
rat
die
within
day
administr
mgkg
owe
high
mortal
observ
group
experi
perform
use
rat
figur
show
activ
nfkb
liver
h
mpsl
treatment
imiquimod
mpsl
n
imiquimod
mpsl
n
mgkg
rat
administr
alter
rel
activ
nfkb
day
howev
activ
repress
significantli
day
rat
administ
figur
imiquimod
mpsl
vs
imiquimod
mpsl
vs
p
conduct
nationwid
epidemiolog
survey
japan
report
high
frequenc
sle
nephrot
syndrom
polymyositisdermatomyos
bronchial
asthma
thrombocytopen
purpura
underli
diseas
patient
corticosteroidinduc
onfh
recent
report
innat
immun
signal
via
contribut
pathogenesi
sle
signal
contribut
pathogenesi
nephrot
syndrom
signal
contribut
pathogenesi
polymyos
dermatomyos
signal
contribut
pathogenesi
bronchial
asthma
signal
contribut
pathogenesi
thrombocytopen
purpura
report
show
innat
immun
signal
via
tlr
contribut
pathogenesi
underli
diseas
patient
corticosteroidinduc
onfh
previous
report
tlr
stimul
induc
osteonecrosi
okazaki
et
al
corticosteroid
treatment
lipopolysaccharid
lp
tlr
ligand
inject
induc
onfh
wistar
rat
suggest
signal
pathway
may
role
pathogenesi
onfh
rat
present
studi
show
administr
ligand
combin
mpsl
treatment
result
develop
onfh
rat
contrast
report
megados
corticosteroid
therapi
recommend
nation
acut
spinal
cord
injuri
protocol
spinal
cord
injuri
result
trauma
induc
onfh
present
studi
onfh
observ
salin
mpsl
group
rat
receiv
tlr
ligand
indic
corticosteroid
alon
fail
induc
onfh
healthi
anim
sever
report
osteonecrosi
anim
model
use
corticosteroid
administr
alon
corticosteroid
administr
alon
led
develop
onfh
spontan
hypertens
rat
shr
howev
treatment
shr
model
differ
corticosteroid
administr
healthi
anim
genet
abnorm
background
shr
report
corticosteroid
alon
led
develop
onfh
leghorn
chicken
histopatholog
examin
specimen
model
show
subchondr
bone
trabecula
femor
head
disappear
diminut
bone
trabecula
similar
appear
microct
imag
osteoporosi
anim
model
clear
whether
result
osteonecrosi
addit
yamamoto
et
al
report
osteonecrosi
rabbit
model
characterist
rabbit
model
osteonecrosi
develop
metaphysi
femor
head
treatment
healthi
rabbit
corticosteroid
hand
yamamoto
et
al
also
report
corticosteroid
treatment
lp
administr
led
develop
osteonecrosi
femor
head
metaphysi
rabbit
report
indic
administr
tlr
ligand
crucial
role
develop
femor
head
osteonecrosi
therefor
present
find
suggest
administr
tlr
ligand
combin
subsequ
corticosteroid
treatment
requir
trigger
onset
primari
corticosteroidinduc
onfh
rat
pathogenesi
underli
diseas
treat
corticosteroid
contribut
develop
corticosteroidinduc
onfh
highdos
corticosteroid
treatment
sever
acut
respiratori
syndrom
sar
infect
report
risk
factor
onfh
sar
viru
singlestrand
rna
viru
one
ligand
consequ
believ
pathogenesi
onfh
imiquimod
mpsl
group
resembl
pathogenesi
onfh
corticosteroid
treatment
sar
infect
although
onfh
found
salin
mpsl
group
rat
fact
imiquimod
salin
rat
alcohol
corticosteroid
given
develop
onfh
lower
rate
indic
group
resembl
idiopath
onfh
result
suggest
signal
contribut
develop
idiopath
onfh
indic
infect
singlestrand
rna
viru
one
ligand
could
risk
factor
idiopath
onfh
infect
human
immunodefici
viru
singlestrand
rna
viru
alreadi
report
isol
risk
factor
idiopath
onfh
therefor
result
may
explain
pathogenesi
idiopath
onfh
patient
infect
singlestrand
rna
virus
among
underli
diseas
treat
corticosteroid
sle
report
frequent
observ
onfh
patient
incid
onfh
sle
patient
corticosteroid
therapi
report
present
studi
imiquimod
mpsl
cpgc
mpsl
group
rat
develop
onfh
similar
incid
onfh
patient
sle
well
known
corticosteroid
mainli
metabol
liver
hepat
corticosteroidmetabol
enzym
recent
report
differ
liver
function
observ
patient
corticosteroidinduc
onfh
without
onfh
within
week
corticosteroid
therapi
moreov
ichiseki
et
al
report
disturb
oxid
stress
liver
observ
within
h
oxid
stressinduc
onfh
rat
model
report
suggest
variou
chang
liver
earli
phase
treatment
contribut
develop
onfh
present
studi
found
onfh
occur
within
day
mpsl
treatment
rat
suggest
detect
earli
phase
diseas
mpsl
treatment
import
clarifi
pathogenesi
onfh
also
found
activ
nfkb
liver
day
significantli
repress
corticosteroid
treatment
ligand
administr
auphan
et
al
report
glucocorticoid
potent
antiinflammatori
immunosuppress
agent
repress
nfkb
activ
via
glucocorticoid
receptor
one
critic
compon
inhibitori
effect
glucocorticoid
proinflammatori
immun
respons
therefor
result
suggest
onfh
result
activ
nfkb
via
pathway
follow
subsequ
repress
nfkb
activ
corticosteroid
treatment
wherea
activ
affect
corticosteroid
treatment
therefor
result
indic
repress
activ
use
specif
inhibitor
interfer
develop
onfh
spite
simultan
repress
nfkb
activ
result
mpsl
treatment
report
ikk
inhibitor
ikk
b
inhibitor
potenti
inhibit
nfkb
activ
present
studi
mpsl
treatment
significantli
repress
activ
nfkb
imiquimod
mpsl
compar
imiquimod
salin
rat
figur
accordingli
coadministr
mpsl
repress
activ
nfkb
imiquimod
mpsl
compar
imiquimod
mpsl
rat
figur
contrast
mpsl
treatment
alter
activ
imiquimod
mpsl
compar
imiquimod
salin
rat
figur
wherea
coadministr
mpsl
significantli
repress
activ
imiquimod
mpsl
compar
imiquimod
mpsl
rat
figur
coadministr
mpsl
significantli
lower
incid
onfh
repress
activ
find
confirm
effect
corticosteroid
treatment
transcript
factor
activ
liver
trigger
develop
onfh
repress
nfkb
activ
corticosteroid
treatment
boost
develop
onfh
conclus
present
studi
show
corticosteroid
treatment
administr
ligand
caus
onfh
rat
differ
nfkb
activ
liver
induc
corticosteroid
treatment
trigger
develop
onfh
although
remain
unclear
signal
transduct
liver
lead
femor
head
osteonecrosi
present
studi
suggest
pathogenesiscondit
underli
diseas
treat
corticosteroid
contribut
develop
onfh
might
help
explain
onfh
develop
develop
corticosteroid
therapi
dosag
expect
normal
inflammatori
statu
new
biolog
inflammatori
diseas
prevent
onfh
near
futur
work
support
part
grantsinaid
young
scientist
b
scientif
research
b
hm
japanes
societi
promot
scienc
astep
japan
scienc
technolog
agenc
author
declar
conflict
interest
